# Synthesis of Milestone 1: Verified Clinical, Technical & Integrity Research Ledger

**Date**: 2026-09-22T00:50:30+05:30  
**Orchestrator**: Project Orchestrator  
**Inputs**:
1. Explorer M1-1: `C:\Users\imgk3\teamwork_projects\colonoscopy_ai_guide\.agents\explorer_m1_1\clinical_ledger.md` (79.8 KB)
2. Explorer M1-2: `C:\Users\imgk3\teamwork_projects\colonoscopy_ai_guide\.agents\explorer_m1_2\technical_ledger.md`
3. Explorer M1-3: `C:\Users\imgk3\teamwork_projects\colonoscopy_ai_guide\.agents\explorer_m1_3\integrity_chakra_ledger.md` (76.8 KB)

---

## 1. Consensus Findings & Verified Invariants

### 1.1 Clinical Invariants & Metrics
- **Anatomy & Screening**: Complete large intestine spans 8 sequential segments (cecum with appendiceal orifice and ileocecal valve, ascending, hepatic flexure, transverse, splenic flexure, descending, sigmoid, rectum). Minimum withdrawal time $\ge$6 minutes (optimal 8–9 min). Cecal intubation rate target $\ge$95%.
- **ADR Significance**: Corley et al. (*NEJM* 2014) established that each 1.0% absolute increase in Adenoma Detection Rate (ADR) confers a 3.0% reduction in interval colorectal cancer (CRC) incidence and a 5.0% reduction in fatal CRC.
- **Adenoma Miss Rate (AMR)**: Baseline tandem colonoscopy shows 20–26% AMR for standard colonoscopy, rising up to 34–35% for diminutive ($\le$5 mm), flat (Paris 0-II), and serrated lesions (SSLs).
- **Clinical Trial Evidence**:
  - Across 41 RCTs (31,789 patients), CADe increases ADR (RR 1.20, 95% CI 1.14–1.27) and cuts AMR by 55% (RR 0.45).
  - *Critical clinical nuance*: ADR gains are concentrated in diminutive polyps ($\le$5 mm) with negligible malignant potential. Advanced adenoma detection is virtually unchanged (RR 1.01).
  - *Side effects*: Increases non-neoplastic resections by 11% (from 28.8% to 34.0%), adds 6–35 extra surveillance colonoscopies per 10k patients (AGA 2025 model), and causes cognitive deskilling (Budzyń et al., *Lancet Gastro Hep* 2025: -6.0% absolute ADR drop during non-AI colonoscopies post-AI exposure).
- **Commercial Systems**: All 6 systems (Medtronic GI Genius, Fujifilm CAD EYE, Olympus ENDO-AID, NEC WISE VISION, Pentax Discovery, MAGENTIQ-COLO) operate under a real-time inline hardware budget strictly $<40$ ms latency.

### 1.2 AI Architecture Lineage & Benchmarks
- **Lineage**:
  - Era 1: Handcrafted color wavelets, edge co-occurrence $\to$ SegNet, early FCN, YOLOv2.
  - Era 2: U-Net (2015, 31.0M, 53 FPS), UNet++, ResUNet++, PraNet (2020, 32.55M, PPD + Reverse Attention, weighted BCE + IoU), HarDNet-MSEG (2021, 33.34M, 88 FPS, low DRAM traffic), SANet (2021, 23.9M).
  - Era 3: Polyp-PVT (2021, 44.6M/25.1M PVTv2, CFM + CIM + Graph-SAM), SSFormer (2022), ColonFormer (2022, 46.64M, MiT-B3, non-monotonic scaling beyond B3), CFA-Net (2023, 30.1M).
  - Era 4: Foundation models (SAM, MedSAM), State-Space Models (EndoMamba 2024, 25.4M, $O(PTm)$ selective scan, 47 FPS at T=128 frames).
- **5-Dataset Benchmark Ground Truth (Mean Dice / Mean IoU)**:
  - Kvasir-SEG: U-Net (0.818/0.746), PraNet (0.898/0.840), SANet (0.904/0.847), Polyp-PVT (0.917/0.864), ColonFormer (0.922/0.871), CFA-Net (0.923/0.873).
  - CVC-ClinicDB: U-Net (0.823/0.755), PraNet (0.899/0.849), SANet (0.916/0.859), Polyp-PVT (0.937/0.889), ColonFormer (0.941/0.895), CFA-Net (0.933/0.885). (*Note: Seen-domain in-sequence caveat mandatory*).
  - CVC-ColonDB: U-Net (0.512/0.444), PraNet (0.709/0.640), SANet (0.753/0.670), Polyp-PVT (0.808/0.727), ColonFormer (0.815/0.738).
  - ETIS-Larib: U-Net (0.398/0.335), PraNet (0.628/0.567), SANet (0.750/0.654), Polyp-PVT (0.787/0.706), ColonFormer (0.811/0.732).
  - CVC-300: U-Net (0.710/0.627), PraNet (0.871/0.797), SANet (0.888/0.815), Polyp-PVT (0.900/0.833), ColonFormer (0.906/0.842). (*Note: 58 identical frames with ColonDB; report separately*).

### 1.3 Benchmark Integrity & ChakraModel Research
- **Flaw 1: CVC-ClinicDB Video Leakage**: All 62 PraNet test frames originate from the same video sequences as the 550 training frames (30 verified near-duplicate links). Random frame-level splits cause +12–15% artificial Dice inflation.
- **Flaw 2: ColonDB ↔ CVC-300 Overlap**: 58 identical frames (59 identical masks). They must NEVER be pooled or merged.
- **Flaw 3: HyperKvasir Segmented Duplication**: 1,000/1,000 segmented images are byte-identical SHA-256 duplicates of Kvasir-SEG (0 extra segmented data).
- **Flaw 4: Blindness to False Alarms**: Standard test sets have 100% polyp prevalence. In reality, >95% of frames are normal mucosa. ChakraModel integrates 4,275 polyp-free frames from 23 PolypGen sequences to quantify False Alarm Rate (FAR).
- **ChakraModel Pivot & Results**:
  - Pivot from building a "lightweight Transformer" to measuring benchmark inflation.
  - ChakraTransformer failure: ViT-L/16 (309.2M params) achieved only Kvasir Dice 0.838 / ClinicDB 0.771, falling behind 2015 U-Net on ClinicDB; 7.76 FPS FP32.
  - 128px experiments collapsed without pretraining (0.28–0.77 Dice).
  - ChakraXAttnUNet v2: Swin-T + Dual-Path cross-attention skip routing (28.6M params).
  - Experimental protocol: `leakbench` running E1 (clean comparison on `splits_v2`), E2 (validation leakage drift), E3 (ClinicDB 5-fold CV isolating video leakage inflation).
  - `splits_v2`: Group-aware split (1,228 train / 222 val, 0 groups spanning train/val).

---

## 2. Resolved Nuances
- **Dataset Naming**: Distinguish `CVC-ClinicDB` (612 frames) from `CVC-ColonDB` (380 frames) and `CVC-300 / EndoScene` (60 test frames, 58 shared with ColonDB).
- **PolypDB Candidate**: Exclude from pretraining due to $\ge$25 verified Kvasir test duplicate links.
- **PICCOLO Release 0.1**: 3,433 frames across 76 lesions (40 videos) with Paris and size classifications (21 diminutive $\le$5mm, 16 small 6–9mm, 31 large $\ge$10mm); 0 split leakage.

---

## 3. Ready-to-Implement Deliverables
- 50 standardized tooltip definitions ready for `assets/js/main.js`.
- 48 verified references ready for `pages/11-references.html`.
- Complete Chart.js data schemas ready for `assets/js/charts.js`.
- Design tokens and component specifications ready for `assets/css/main.css`.
